Published in Am J Hum Genet on September 13, 2002
Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell (2010) 3.08
Nonrandom distribution and frequencies of genomic and EST-derived microsatellite markers in rice, wheat, and barley. BMC Genomics (2005) 2.40
Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA. Am J Hum Genet (2009) 2.12
The active FMR1 promoter is associated with a large domain of altered chromatin conformation with embedded local histone modifications. Proc Natl Acad Sci U S A (2006) 2.00
Promoter-bound trinucleotide repeat mRNA drives epigenetic silencing in fragile X syndrome. Science (2014) 1.54
Polycomb mediated epigenetic silencing and replication timing at the INK4a/ARF locus during senescence. PLoS One (2009) 1.48
R-loops associated with triplet repeat expansions promote gene silencing in Friedreich ataxia and fragile X syndrome. PLoS Genet (2014) 1.46
The biological effects of simple tandem repeats: lessons from the repeat expansion diseases. Genome Res (2008) 1.46
The FMR1 gene and fragile X-associated tremor/ataxia syndrome. Am J Med Genet B Neuropsychiatr Genet (2009) 1.37
Instability and chromatin structure of expanded trinucleotide repeats. Trends Genet (2009) 1.36
Dnmt1 deficiency promotes CAG repeat expansion in the mouse germline. Hum Mol Genet (2008) 1.28
The unstable repeats--three evolving faces of neurological disease. Neuron (2013) 1.26
SIRT1 inhibition alleviates gene silencing in Fragile X mental retardation syndrome. PLoS Genet (2008) 1.16
Histone deacetylases suppress CGG repeat-induced neurodegeneration via transcriptional silencing in models of fragile X tremor ataxia syndrome. PLoS Genet (2010) 1.11
The distribution of repressive histone modifications on silenced FMR1 alleles provides clues to the mechanism of gene silencing in fragile X syndrome. Hum Mol Genet (2010) 1.04
Long-term stability of demethylation after transient exposure to 5-aza-2'-deoxycytidine correlates with sustained RNA polymerase II occupancy. Mol Cancer Res (2010) 1.04
45S rDNA regions are chromosome fragile sites expressed as gaps in vitro on metaphase chromosomes of root-tip meristematic cells in Lolium spp. PLoS One (2008) 0.97
Identification of fragile X syndrome specific molecular markers in human fibroblasts: a useful model to test the efficacy of therapeutic drugs. Hum Mutat (2014) 0.95
Epigenetic findings in autism: new perspectives for therapy. Int J Environ Res Public Health (2013) 0.95
Development of histone deacetylase inhibitors as therapeutics for neurological disease. Future Neurol (2009) 0.93
FMR1 epigenetic silencing commonly occurs in undifferentiated fragile X-affected embryonic stem cells. Stem Cell Reports (2014) 0.92
iPSC-derived forebrain neurons from FXS individuals show defects in initial neurite outgrowth. Stem Cells Dev (2014) 0.92
Epigenetic changes and non-coding expanded repeats. Neurobiol Dis (2010) 0.91
The fragile x mental retardation syndrome 20 years after the FMR1 gene discovery: an expanding universe of knowledge. Clin Biochem Rev (2011) 0.91
Clinical and molecular implications of mosaicism in FMR1 full mutations. Front Genet (2014) 0.89
NF-Y, AP2, Nrf1 and Sp1 regulate the fragile X-related gene 2 (FXR2). Biochem J (2006) 0.88
High-Throughput Screening to Identify Compounds That Increase Fragile X Mental Retardation Protein Expression in Neural Stem Cells Differentiated From Fragile X Syndrome Patient-Derived Induced Pluripotent Stem Cells. Stem Cells Transl Med (2015) 0.87
Epigenetics in Friedreich's Ataxia: Challenges and Opportunities for Therapy. Genet Res Int (2013) 0.87
The gene encoding the fragile X RNA-binding protein is controlled by nuclear respiratory factor 2 and the CREB family of transcription factors. Nucleic Acids Res (2006) 0.87
Plant 45S rDNA clusters are fragile sites and their instability is associated with epigenetic alterations. PLoS One (2012) 0.87
Epigenetic characterization of the FMR1 promoter in induced pluripotent stem cells from human fibroblasts carrying an unmethylated full mutation. Stem Cell Reports (2014) 0.86
The impact of local genome sequence on defining heterochromatin domains. PLoS Genet (2009) 0.86
Epigenetics in nucleotide repeat expansion disorders. Semin Neurol (2012) 0.85
Molecular mechanisms regulating the defects in fragile X syndrome neurons derived from human pluripotent stem cells. Stem Cell Reports (2014) 0.85
Transcriptionally Repressive Chromatin Remodelling and CpG Methylation in the Presence of Expanded CTG-Repeats at the DM1 Locus. J Nucleic Acids (2013) 0.84
Reactivation of FMR1 by CRISPR/Cas9-Mediated Deletion of the Expanded CGG-Repeat of the Fragile X Chromosome. PLoS One (2016) 0.82
The promise and perils of HDAC inhibitors in neurodegeneration. Ann Clin Transl Neurol (2014) 0.81
Reciprocal changes in DNA methylation and hydroxymethylation and a broad repressive epigenetic switch characterize FMR1 transcriptional silencing in fragile X syndrome. Clin Epigenetics (2016) 0.80
From FMRP function to potential therapies for fragile X syndrome. Neurochem Res (2013) 0.80
Two breakpoint clusters at fragile site FRA3B form phased nucleosomes. Genome Res (2004) 0.79
Polycomb group complexes are recruited to reactivated FMR1 alleles in Fragile X syndrome in response to FMR1 transcription. Hum Mol Genet (2014) 0.79
Randomly detected genetically modified (GM) maize (Zea mays L.) near a transport route revealed a fragile 45S rDNA phenotype. PLoS One (2013) 0.79
Changes in expression of the long non-coding RNA FMR4 associate with altered gene expression during differentiation of human neural precursor cells. Front Genet (2015) 0.78
X-linked mental retardation and epigenetics. J Cell Mol Med (2006) 0.78
Human pluripotent stem cell models of Fragile X syndrome. Mol Cell Neurosci (2015) 0.77
Fragile X mental retardation protein regulates olfactory sensitivity but not odorant discrimination. Chem Senses (2015) 0.76
Modeling Fragile X Syndrome Using Human Pluripotent Stem Cells. Genes (Basel) (2016) 0.75
Astrocyte-Secreted Factors Selectively Alter Neural Stem and Progenitor Cell Proliferation in the Fragile X Mouse. Front Cell Neurosci (2016) 0.75
Establishment of Reporter Lines for Detecting Fragile X Mental Retardation (FMR1) Gene Reactivation in Human Neural Cells. Stem Cells (2016) 0.75
Recent advances in assays for the fragile X-related disorders. Hum Genet (2017) 0.75
A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res (1988) 77.80
Translating the histone code. Science (2001) 56.77
The language of covalent histone modifications. Nature (2000) 44.92
Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature (2001) 19.67
Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature (2001) 19.54
Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature (1998) 18.36
Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature (2000) 18.26
Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell (1991) 17.00
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet (1998) 13.27
Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell (1991) 12.27
Structure and ligand of a histone acetyltransferase bromodomain. Nature (1999) 10.08
A histone H3 methyltransferase controls DNA methylation in Neurospora crassa. Nature (2001) 8.27
Rb targets histone H3 methylation and HP1 to promoters. Nature (2001) 8.26
Structure and function of a human TAFII250 double bromodomain module. Science (2000) 8.00
Absence of expression of the FMR-1 gene in fragile X syndrome. Cell (1991) 7.04
Correlation between histone lysine methylation and developmental changes at the chicken beta-globin locus. Science (2001) 6.00
Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science (1991) 5.99
Requirement of CHROMOMETHYLASE3 for maintenance of CpXpG methylation. Science (2001) 5.50
Methylation of histone H3 at lysine 4 is highly conserved and correlates with transcriptionally active nuclei in Tetrahymena. Proc Natl Acad Sci U S A (1999) 5.33
The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet (1993) 4.57
DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet (1992) 4.22
Differentially methylated forms of histone H3 show unique association patterns with inactive human X chromosomes. Nat Genet (2001) 3.63
Histone H3 lysine 9 methylation is an epigenetic imprint of facultative heterochromatin. Nat Genet (2001) 3.46
The structure of mouse HP1 suggests a unique mode of single peptide recognition by the shadow chromo domain dimer. EMBO J (2000) 3.04
Translational suppression by trinucleotide repeat expansion at FMR1. Science (1995) 2.73
Role of DNA methylation in the regulation of transcription. Curr Opin Genet Dev (1994) 2.61
Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat Genet (1999) 2.59
Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population. Am J Hum Genet (1993) 1.71
DNA methylation is linked to deacetylation of histone H3, but not H4, on the imprinted genes Snrpn and U2af1-rs1. Mol Cell Biol (2001) 1.55
Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene. Hum Mol Genet (1999) 1.53
High resolution methylation analysis of the FMR1 gene trinucleotide repeat region in fragile X syndrome. Hum Mol Genet (1993) 1.42
Gene silencing. Methylation meets acetylation. Nature (1998) 1.41
Parent-specific complementary patterns of histone H3 lysine 9 and H3 lysine 4 methylation at the Prader-Willi syndrome imprinting center. Am J Hum Genet (2001) 1.36
In vitro reactivation of the FMR1 gene involved in fragile X syndrome. Hum Mol Genet (1998) 1.34
Nuclease sensitivity of permeabilized cells confirms altered chromatin formation at the fragile X locus. Somat Cell Mol Genet (1996) 0.96
The mojo of methylation. Nat Genet (1999) 0.92
The mGluR theory of fragile X mental retardation. Trends Neurosci (2004) 8.88
Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci U S A (2002) 6.45
Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron (2008) 6.26
Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway. Nat Neurosci (2004) 4.69
A decade of molecular studies of fragile X syndrome. Annu Rev Neurosci (2002) 3.54
An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities. Genet Med (2011) 3.51
Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome. Neuron (2007) 3.17
The pathophysiology of fragile x syndrome. Annu Rev Genomics Hum Genet (2007) 2.85
RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila. Neuron (2003) 2.81
Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia. Am J Hum Genet (2010) 2.70
Phosphorylation influences the translation state of FMRP-associated polyribosomes. Hum Mol Genet (2003) 2.66
RNA and microRNAs in fragile X mental retardation. Nat Cell Biol (2004) 2.63
A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses. Immunity (2009) 2.59
Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways. Hum Mol Genet (2007) 2.55
Age-associated DNA methylation in pediatric populations. Genome Res (2012) 2.53
Relative burden of large CNVs on a range of neurodevelopmental phenotypes. PLoS Genet (2011) 2.46
Molecular mechanisms of fragile X syndrome: a twenty-year perspective. Annu Rev Pathol (2011) 2.39
Microdeletions of 3q29 confer high risk for schizophrenia. Am J Hum Genet (2010) 2.38
The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development. Proc Natl Acad Sci U S A (2004) 2.34
Reversible inhibition of PSD-95 mRNA translation by miR-125a, FMRP phosphorylation, and mGluR signaling. Mol Cell (2011) 2.27
Replication stress induces tumor-like microdeletions in FHIT/FRA3B. Proc Natl Acad Sci U S A (2007) 2.27
Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA. Am J Hum Genet (2009) 2.12
Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors. Proc Natl Acad Sci U S A (2007) 2.10
Replication stress induces genome-wide copy number changes in human cells that resemble polymorphic and pathogenic variants. Am J Hum Genet (2009) 2.07
Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila. Nat Chem Biol (2008) 2.04
FMRP phosphorylation reveals an immediate-early signaling pathway triggered by group I mGluR and mediated by PP2A. J Neurosci (2007) 2.02
Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome. J Neurosci (2010) 1.89
S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade. J Biol Chem (2008) 1.87
Local RNA translation at the synapse and in disease. J Neurosci (2011) 1.83
Fragile X syndrome. Eur J Hum Genet (2008) 1.81
Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen. Sci Transl Med (2012) 1.72
Transcription, translation and fragile X syndrome. Curr Opin Genet Dev (2006) 1.72
New insights into fragile X syndrome: from molecules to neurobehaviors. Trends Biochem Sci (2003) 1.68
Signatures of founder effects, admixture, and selection in the Ashkenazi Jewish population. Proc Natl Acad Sci U S A (2010) 1.64
A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci. PLoS Genet (2012) 1.52
Polyglutamine domain modulates the TBP-TFIIB interaction: implications for its normal function and neurodegeneration. Nat Neurosci (2007) 1.46
Functional distinctions between IMP dehydrogenase genes in providing mycophenolate resistance and guanine prototrophy to yeast. J Biol Chem (2003) 1.39
Microarray-based mutation detection in the dystrophin gene. Hum Mutat (2008) 1.39
Physiological identification of human transcripts translationally regulated by a specific microRNA. Hum Mol Genet (2005) 1.39
Hemizygous mutations in SNAP29 unmask autosomal recessive conditions and contribute to atypical findings in patients with 22q11.2DS. J Med Genet (2012) 1.33
Properties of an intergenic terminator and start site switch that regulate IMD2 transcription in yeast. Mol Cell Biol (2008) 1.33
Use of an in vivo reporter assay to test for transcriptional and translational fidelity in yeast. J Biol Chem (2002) 1.30
Large-scale screening of yeast mutants for sensitivity to the IMP dehydrogenase inhibitor 6-azauracil. Yeast (2004) 1.29
Subtelomeric hotspots of aberrant 5-hydroxymethylcytosine-mediated epigenetic modifications during reprogramming to pluripotency. Nat Cell Biol (2013) 1.27
The unstable repeats--three evolving faces of neurological disease. Neuron (2013) 1.26
New perspectives on the biology of fragile X syndrome. Curr Opin Genet Dev (2012) 1.23
A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels. Blood (2007) 1.22
Mosaic FMR1 deletion causes fragile X syndrome and can lead to molecular misdiagnosis: a case report and review of the literature. Am J Med Genet A (2008) 1.21
Genome-wide DNA hydroxymethylation changes are associated with neurodevelopmental genes in the developing human cerebellum. Hum Mol Genet (2012) 1.21
Proinflammatory cytokines underlying the inflammation of Crohn's disease. Curr Opin Gastroenterol (2010) 1.18
Identification of novel FMR1 variants by massively parallel sequencing in developmentally delayed males. Am J Med Genet A (2010) 1.16
Neurogenetics: advancing the "next-generation" of brain research. Neuron (2010) 1.16
Phosphorylation of FMRP inhibits association with Dicer. RNA (2009) 1.16
T cell-intrinsic requirement for NF-kappa B induction in postdifferentiation IFN-gamma production and clonal expansion in a Th1 response. J Immunol (2003) 1.14
Fragile X protein functions with lgl and the par complex in flies and mice. Dev Cell (2005) 1.14
The fragile X mental retardation protein, FMRP, recognizes G-quartets. Ment Retard Dev Disabil Res Rev (2004) 1.14
Fragile X mental retardation protein FMRP binds mRNAs in the nucleus. Mol Cell Biol (2008) 1.11
Arginines of the RGG box regulate FMRP association with polyribosomes and mRNA. Hum Mol Genet (2010) 1.08
Identification and characterization of the methyl arginines in the fragile X mental retardation protein Fmrp. Hum Mol Genet (2005) 1.07
Metabolic regulation of IMD2 transcription and an unusual DNA element that generates short transcripts. Mol Cell Biol (2007) 1.06
Array-based assay detects genome-wide 5-mC and 5-hmC in the brains of humans, non-human primates, and mice. BMC Genomics (2014) 1.03
Fragile X syndrome: an update and review for the primary pediatrician. Clin Pediatr (Phila) (2005) 1.01
Argonaute2 is essential for mammalian gastrulation and proper mesoderm formation. PLoS Genet (2007) 0.99
Genome-wide analysis validates aberrant methylation in fragile X syndrome is specific to the FMR1 locus. BMC Med Genet (2013) 0.97
Gene expression profiles in a transgenic animal model of fragile X syndrome. Neurobiol Dis (2002) 0.96
Arginine methylation of RNA-binding proteins regulates cell function and differentiation. Mol Reprod Dev (2012) 0.94
Occupancy and synergistic activation of the FMR1 promoter by Nrf-1 and Sp1 in vivo. Hum Mol Genet (2004) 0.93
Array-based FMR1 sequencing and deletion analysis in patients with a fragile X syndrome-like phenotype. PLoS One (2010) 0.93
Fragile X protein family member FXR1P is regulated by microRNAs. RNA (2010) 0.92
A genetic screen for terminator function in yeast identifies a role for a new functional domain in termination factor Nab3. Nucleic Acids Res (2012) 0.91
Dissection of the molecular basis of mycophenolate resistance in Saccharomyces cerevisiae. Yeast (2005) 0.90
Translation regulation of mRNAs by the fragile X family of proteins through the microRNA pathway. RNA Biol (2009) 0.89
Modulating huntingtin half-life alters polyglutamine-dependent aggregate formation and cell toxicity. J Neurochem (2004) 0.89
Neuroscience: fragile dopamine. Nature (2008) 0.87
The gene encoding the fragile X RNA-binding protein is controlled by nuclear respiratory factor 2 and the CREB family of transcription factors. Nucleic Acids Res (2006) 0.87
Detection of the mycophenolate-inhibited form of IMP dehydrogenase in vivo. Proc Natl Acad Sci U S A (2004) 0.85
Yeast Nab3 protein contains a self-assembly domain found in human heterogeneous nuclear ribonucleoprotein-C (hnRNP-C) that is necessary for transcription termination. J Biol Chem (2012) 0.85
Empirical evaluation of oligonucleotide probe selection for DNA microarrays. PLoS One (2010) 0.84
Fragile X mental retardation protein: past, present and future. Curr Protein Pept Sci (2012) 0.83
Molecular diagnosis of Beckwith-Wiedemann syndrome using quantitative methylation-sensitive polymerase chain reaction. Genet Med (2006) 0.82
Toward pluripotency by reprogramming: mechanisms and application. Protein Cell (2013) 0.81
Termination of Transcription of Short Noncoding RNAs by RNA Polymerase II. Annu Rev Biochem (2015) 0.81
A network of interdependent molecular interactions describes a higher order Nrd1-Nab3 complex involved in yeast transcription termination. J Biol Chem (2013) 0.80
Development and characterization of antibodies that immunoprecipitate the FMR1 protein. Methods Mol Biol (2003) 0.79
Exploring the zebra finch Taeniopygia guttata as a novel animal model for the speech-language deficit of fragile X syndrome. Results Probl Cell Differ (2012) 0.78
A new regulatory function of the region proximal to the RGG box in the fragile X mental retardation protein. J Cell Sci (2011) 0.78
Amyloid-like assembly of the low complexity domain of yeast Nab3. Prion (2015) 0.77
Fragile X family members have important and non-overlapping functions. Biomol Concepts (2011) 0.76
Genomic tics in tourette syndrome. Biol Psychiatry (2012) 0.75
The human genome: a diamond in the rough. Curr Opin Genet Dev (2012) 0.75
Implication of tumor stem-like cells in the tumorigenesis of sporadic paraganglioma. Med Oncol (2013) 0.75
Speciation analysis of aluminium(III) in natural waters and biological fluids by complexing with various catechols followed by differential pulse voltammetry detection. Analyst (2002) 0.75
[Establishment of a sandwich ELISA method for detection of reporter chloramphenicol acetyltransferase gene]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi (2002) 0.75